ZAWYA: Burjeel Holdings assigned BB+ by S&P and Ba2 by Moody’s

About this update from Burjeel Holdings Plc

Assigned BB+ by S&P and Ba2 by Moody’s; Establishes USD 1.5 Billion Sukuk ProgrammeAbu Dhabi, United Arab Emirates: Burjeel Holdings PLC (“Burjeel” or “the Group”), a leading super-specialty healthcare services provider in the GCC listed on the Abu Dhabi Securities Exchange (SYMBOL: BURJEEL; ISIN: AEE01119B224), today announced that it has received first-time corporate credit ratings from S&P Global Ratings and Moody’s Ratings, alongside the establishment of a USD 1.5 billion Senior Unsecured Sukuk Programme.The assignment of ratings marks an important milestone for Burjeel Holdings and reflects the Group’s robust business profile, disciplined financial policy, strong corporate governance and continued commitment to transparency.The Sukuk Programme has been established through Burjeel Sukuk Limited, a special purpose vehicle established for this purpose, and is admitted to the London Stock Exchange’s International Securities Market. The Programme provides Burjeel Holdings with a flexible Shariah-compliant platform to access debt capital markets, supporting the Group’s strategy to diversify funding sources, strengthen its long-term capital structure and pursue strategic investments in advanced clinical care, research, medical education, digital transformation and AI-enabled healthcare innovation.S&P Global RatingsBB+, Stable outlookS&P Global Ratings has assigned Burjeel Holdings a ‘BB+’ issuer credit rating with a Stable outlook. The rating reflects Burjeel’s strong position as one of the largest healthcare services providers in the UAE, the defensive nature of the healthcare sector, the Group’s disciplined financial policy, and expectations that leverage will remain consistent with the rating level while EBITDA margins recover, supported by the ramp-up of growth assets and increasing patient yield.Moody’s RatingsBa2, Stable outlookMoody’s Ratings has assigned Burjeel Holdings a Ba2 corporate family rating with a Stable outlook. The rating reflects Burjeel’s strong market position in Abu Dhabi, its expanding presence across the UAE, Saudi Arabia and Oman, good profitability across the Burjeel Hospital brand, the growing contribution from its complex care and super-specialty division, as well as solid credit metrics and an improving liquidity profile.Burjeel Holdings continues to benefit from favourable long-term healthcare fundamentals in the UAE and the ...

View stock analysis, news, and events for Burjeel Holdings Plc